Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
AKORN Add to My Watchlist (NSDQ: AKRX) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Akorn 1.49 +0.13 (+9.56%) 142,542
2500 Millbrook Drive
Buffalo Grove, IL 60089 US
(847) 279-6100
(847) 279-6123 fax
www.akorn.com
CEO Rajat Rai
Auditor BDO Seidman, LLP
Exchange Traded NQ
ISIN Number US0097281069
CIK Number 3116
NAICS Code 325412
Business Summary
The company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.
Number of Employees 351
Share Fundamentals
Market Cap 134.68M
Shares Outstanding 90.39M
Float 55.50M
Short Interest 4.14M
Financial Strength
Revenue (TTM) $83,747,000
Earnings (TTM) -$24,719,000
Quick Ratio 0.5:1
Current Ratio 1.2:1
Total Debt/Equity 0.22:1
Profitability
Gross Margin 25.8%
EBITDA Margin -11.3%
Profit Margin -29.5%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs